QuadMedicine Inc.
Founded in 2016 and listed on KOSDAQ in 2025, QuadMedicine is a microneedle-platform CDMO with its S-MAP and C-MAP drug delivery technologies.
Price
Change
Market cap
Products & technology
- Separable Microneedle Array PatchDrug delivery platform for small-molecule, biologic, and vaccine products
- Coated Microneedle Array PatchDelivery platform for vaccines including recombinant, attenuated, inactivated, mRNA, and DNA vaccines
Regulatory approvals
data.go.kr2 Korean MFDS device approvals · 2020–2022
- MFDSStimulator, skin, medicine absorption2022-06-07Product approval · Class 2제인 22-4431 호
- MFDSStimulator, skin, medicine absorption2020-05-21Product approval · Class 2제인 20-4403 호
R&D and key agreements
Source: DART corporate disclosureHPV 관련 암 예방 정부출연과제 · HPV 관련 암 예방 · 진행중(2025년 4월~2026년 12월) · Under Article 19(1) of Korea's National R&D Innovation Act, once revenue occurs the company pays a technology royalty capped at the lower of 5% of revenue or 10% of the government grant.
Companies approved for the same productsPharma & CDMO
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
KOSDAQ-listed medical device maker producing disposable acupuncture needles, cupping cups, and hyaluronic acid dermal fillers.
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition